Interleukin-17A stimulates granulocyte-macrophage colony-stimulating factor release by murine osteoblasts in the presence of 1,25-dihydroxyvitamin D 3 and inhibits murine osteoclast development in vitro

Arthritis and Rheumatism

Volumn 65, Issue 2, 2013, Pages 436-446

  Balani, Deepak ^a   Aeberli, Daniel ^a   Hofstetter, Willy ^a   Seitz, Michael ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; CALCITRIOL; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 17; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BONE MARROW CELL; CELL CULTURE; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; IN VITRO STUDY; MALE; MOUSE; NONHUMAN; OSTEOCLASTOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION;

ANIMALS; CALCITRIOL; CELL COUNT; CELL DIFFERENTIATION; CELLS, CULTURED; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; INTERLEUKIN-17; MALE; MICE; MICE, INBRED C57BL; OSTEOBLASTS; OSTEOCLASTS; OSTEOPROTEGERIN;

EID: 84873865663     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.37762     Document Type: Article

References (47)

1. Teitelbaum SL,. Bone resorption by osteoclasts. Science 2000; 289: 1504-8.
2. McInnes IB, Schett G,. Cytokines in the pathogenesis of rheumatoid arthritis. Nat Rev Immunol 2007; 7: 429-42.
3. Firestein GS,. Evolving concepts of rheumatoid arthritis. Nature 2003; 43: 356-61.
4. Hulkower K, Brosnan C, Aquino D, Cammer W, Kulshrestha S, Guida M, et al. Expression of CSF-1, c-fms, and MCP-1 in the central nervous system of rats with experimental allergic encephalomyelitis. J Immunol 1993; 150: 2525-33.
5. Rettenmier CW, Roussel MF, Ashmun RA, Ralph P, Price K, Sherr CJ,. Synthesis of membrane-bound CSF-1 and downmodulation of CSF-1 receptors in NIH 3T3 cells transformed by cotransfection of the human CSF-1 and c-fms genes. Mol Cell Biol 1987; 7: 2378-87.
6. Naito A, Azuma S, Tanaka S, Miyazaki T, Takaki S, Takatsu K, et al. Severe osteopetrosis, defective IL-1 signalling and lymph node organogenesis in TRAF6-deficient mice. Genes Cells 1999; 4: 353-62.
7. Lomaga MA, Yeh WC, Sarosi I, Duncan GS, Furlonge C, Ho A, et al. TRAF6 deficiency results in osteopetrosis and defective IL-1, CD40, and LPS signaling. Genes Dev 1999; 13: 1015-24.
8. Walsh MC, Choi Y,. Biology of the TRANCE axis. Cytokine Growth Factor Rev 2003; 14: 251-63.
9. Theill LE, Boyle WJ, Penninger JM,. RANK-L and RANK: T cells, bone loss, and mammalian evolution. Annu Rev Immunol 2002; 20: 795-823.
10. 3 on genes involved in calcium homeostasis. J Bone Miner Res 2007; 22: V16-9.
11. 3 in osteoclast differentiation and function. Methods Enzymol 1997; 282: 223-35.
12. Compston J,. Bone marrow and bone: a functional unit. J Endocrinol 2002; 173: 387-94.
13. Takayanagi H,. Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems. Nat Rev Immunol 2007; 7: 292-304.
14. Dewhirst F, Stashenko P, Mole J, Tsurumachi T,. Purification and partial sequence of human osteoclast-activating factor: identity with IL-1β. J Immunol 1985; 135: 2562-8.
15. Yeo L, Toellner KM, Salmon M, Filer A, Buckley CD, Raza K, et al. Cytokine mRNA profiling identifies B cells as a major source of RANKL in rheumatoid arthritis. Ann Rheum Dis 2011; 70: 2022-8.
16. Kawai T, Matsuyama T, Hosokawa Y, Makihira S, Seki M, Karimbux NY, et al. B and T lymphocytes are the primary sources of RANKL in the bone resorptive lesion of periodontal disease. Am J Pathol 2006; 169: 987-98.
17. Udagawa N, Takahashi N, Katagiri T, Tamura T, Wada S, Findlay DM, et al. IL-6 induction of osteoclast differentiation depends on IL-6 receptors expressed on osteoblastic cells but not on osteoclast progenitors. J Exp Med 1995; 182: 1461-8.
18. Yao Z, Li P, Zhang Q, Schwarz EM, Keng P, Arbini A, et al. Tumor necrosis factor-α increases circulating osteoclast precursor numbers by promoting their proliferation and differentiation in the bone marrow through up-regulation of c-Fms expression. J Biol Chem 2006; 281: 11846-55.
19. Kotake S, Udagawa N, Hakoda M, Mogi M, Yano K, Tsuda E, et al. Activated human T cells directly induce osteoclastogenesis from human monocytes: possible role of T cells in bone destruction in rheumatoid arthritis patients. Arthritis Rheum 2001; 44: 1003-12.
20. Kotake S, Udagawa N, Takahashi N, Matsuzaki K, Itoh K, Ishiyama S, et al. IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. J Clin Invest 1999; 103: 1345-52.
21. Horwood NJ, Elliott J, Martin TJ, Gillespie MT,. IL-12 alone and in synergy with IL-18 inhibits osteoclast formation in vitro. J Immunol 2001; 166: 4915-21.
22. Chen Z, Shea J,. Th17 cells: a new fate for differentiating helper T cells. Immunol Res 2008; 41: 87-102.
23. Leavy O,. De novo generation of IL-17-producing T cells. Nat Rev Immunol 2006; 6: 260.
24. O'Brien RL, Roark CL, Born WK,. IL-17-producing γδ T cells. Eur J Immunol 2009; 39: 662-6.
25. Xu S, Cao X,. IL-17 and its expanding biological functions. Cell Mol Immunol 2010; 7: 164-74.
26. Nakae S, Nambu A, Sudo K, Iwakura Y,. Suppression of immune induction of CIA in IL-17-deficient mice. J Immunol 2003; 171: 6173-7.
27. Nagai M, Sato N,. Reciprocal gene expression of osteoclastogenesis inhibitory factor and osteoclast differentiation factor regulates osteoclast formation. Biochem Biophys Res Comm 1999; 257: 719-23.
28. Jovanovic DV, Di Battista JA, Martel-Pelletier J, Jolicoeur FC, He Y, Zhang M, et al. IL-17 stimulates the production and expression of proinflammatory cytokines, IL-1β and TNF-α, by human macrophages. J Immunol 1998; 160: 3513-21.
29. Laan M, Prause O, Miyamoto M, Sjostrand M, Hytonen AM, Kaneko T, et al. A role of GM-CSF in the accumulation of neutrophils in the airways caused by IL-17 and TNF-α. Eur Resp J 2003; 21: 387-93.
30. Numasaki M, Tomioka Y, Takahashi H, Sasaki H,. IL-17 and IL-17F modulate GM-CSF production by lung microvascular endothelial cells stimulated with IL-1β and/or TNF-α. Immunol Lett 2004; 95: 175-84.
31. 3 modulates the expression of a lymphokine (GM-CSF) posttranscriptionally. J Clin Invest 1988; 81: 1819-23.
32. Schreck R, Baeuerle PA,. NF-κB as inducible transcriptional activator of the GM-CSF gene. Mol Cell Biol 1990; 10: 1281-6.
33. Brettingham-Moore KH, Rao S, Juelich T, Shannon MF, Holloway AF,. GM-CSF promoter chromatin remodelling and gene transcription display distinct signal and transcription factor requirements. Nucleic Acids Res 2005; 33: 225-34.
34. Xie S, Li J, Wang JH, Wu Q, Yang P, Hsu HC, et al. IL-17 activates the canonical NF-κB signaling pathway in autoimmune B cells of BXD2 mice to upregulate the expression of regulators of G-protein signaling 16. J Immunol 2010; 184: 2289-96.
35. Shahrara S, Pickens SR, Dorfleutner A, Pope RM,. IL-17 induces monocyte migration in rheumatoid arthritis. J Immunol 2009; 182: 3884-91.
36. Munker R, Gasson J, Ogawa M, Koeffler HP,. Recombinant human TNF induces production of GM-CSF. Nature 1986; 323: 79-81.
37. Broudy VC, Kaushansky K, Segal GM, Harlan JM, Adamson JW,. Tumor necrosis factor type α stimulates human endothelial cells to produce granulocyte/macrophage colony-stimulating factor. Proc Natl Acad Sci U S A 1986; 83: 7467-71.
38. Atanga E, Dolder S, Dauwalder T, Wetterwald A, Hofstetter W,. TNFα inhibits the development of osteoclasts through osteoblast-derived GM-CSF. Bone 2011; 49: 1090-100.
39. Shen F, Ruddy MJ, Plamondon P, Gaffen SL,. Cytokine link osteoblasts and inflammation: microarray analysis of interleukin-17 and TNFα-induced genes in bone cells. J Leuk Biol 2005; 77: 388-99.
40. Lubberts E, Koenders MI, Oppers-Walgreen B, van den Bersselaar L, Coenen-de Roo CJ, Joosten LA, et al. Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion. Arthritis Rheum 2004; 50: 650-9.
41. Goswami J, Hernandez-Santos N, Zuniga LA, Gaffen SL,. A bone-protective role for IL-17R signaling in ovariectomy-induced bone loss. Eur J Immunol 2009; 39: 2831-9.
42. Dougall WC, Glaccum M, Charrier K, Rohrbach K, Brasel K, De Smedt T, et al. RANK is essential for osteoclast and lymph node development. Genes Dev 1999; 13: 2412-24.
43. Khosla S,. Minireview: the OPG/RANKL/RANK system. Endocrinology 2001; 142: 5050-5.
44. Wiktor-Jedrzejczak W, Urbanowska E, Aukerman SL, Pollard JW, Stanley ER, Ralph P, et al. Correction by CSF-1 of defects in the osteopetrotic op/op mouse suggests local, developmental, and humoral requirements for this growth factor. Exp Hematol 1991; 19: 1049-54.
45. Horwood NJ, Elliott J, Martin TJ, Gillespie MT,. Osteotropic agents regulate the expression of osteoclast differentiation factor and osteoprotegerin in osteoblastic stromal cells. Endocrinology 1998; 139: 4743-6.
46. Plater-Zyberk C, Joosten LA, Helsen MM, Koenders MI, Baeuerle PA, van den Berg WB,. Combined blockade of GM-CSF and IL-17 pathways potently suppresses chronic destructive arthritis in a TNFα-independent mouse model. Ann Rheum Dis 2009; 68: 721-8.
47. Menaa C, Devlin RD, Reddy SV, Gazitt Y, Choi SJ, Roodman GD,. Annexin II increases osteoclast formation by stimulating the proliferation of osteoclast precursors in human marrow cultures. J Clin Invest 1999; 103: 1605-13.